Key facts
- Lind Global Fund III LP filed SCHEDULE 13G/A for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 7.9%.
- Date of event: 31 Mar 2026.
Lind Global Fund III LP - 31 Mar 2026 SCHEDULE 13G/A Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing manager
- Lind Global Fund III LP
- Reporting owner
- EASTON JEFF
- Symbol
- ENVB
- Shares outstanding
- 2,048,691 shares
- Disclosed shares
- 161,232 shares
- Ownership percentage
- 7.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 16:15:08 UTC
- Event date
- 31 Mar 2026
- Previous filing
- 04 Feb 2026
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
Lind Global Fund III LP disclosed 7.9% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 31 Mar 2026.
Change
- Previous schedule filing date: 04 Feb 2026.
- Current filing was accepted on 15 May 2026, 16:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lind Global Fund III LP | 7.8% | 158,732 | 150 | 0 | By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Lind Global Partners III LLC | 7.8% | 158,732 | 158,732 | 0 | /s/ Jeff Easton | Jeff Easton, Managing Member | |
| EASTON JEFF | 7.9% | 161,232 | 161,232 | 0 | /s/ Jeff Easton | Jeff Easton |
CIK / CUSIP context first